Neurology-Neuroimmunology & Neuroinflammation Journal Issues Research Articles in November 2022 Edition
December 09, 2022
December 09, 2022
MINNEAPOLIS, Minnesota, Dec. 9 -- Neurology-Neuroimmunology and Neuroinflammation, a peer-reviewed journal for experts in the fields of neuroimmunology and neuroinflammation from the American Academy of Neurology, posted research articles on the following topics in its November 2022 edition:
Research Articles:
* Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
. . .
Research Articles:
* Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
. . .